SPY363.67+1.01 0.28%
DIA299.24+0.50 0.17%
IXIC12,205.85+111.44 0.92%

Cancer Genetics Q3 EPS $(0.58) Up From $(0.82) YoY, Sales $1.57M Down From $2.07M YoY

Cancer Genetics (NASDAQ:CGIX) reported quarterly losses of $(0.58) per share. This is a 29.27 percent increase over losses of $(0.82) per share from the same period last year. The company reported $1.57 million in sales

· 11/12/2020 16:32
Cancer Genetics (NASDAQ:CGIX) reported quarterly losses of $(0.58) per share. This is a 29.27 percent increase over losses of $(0.82) per share from the same period last year. The company reported $1.57 million in sales this quarter. This is a 24.21 percent decrease over sales of $2.07 million the same period last year.